Schedule 13G ownership disclosure

BIODEXA PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 59564R708

Event date: 2024-07-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-063544
Form type
SC 13G
Filer
Biodexa Pharmaceuticals Plc
CIK
CIK 1643918
Filed
Jul 23, 2024
Reporting period
Jul 15, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub